| 发明名称 | Biomarkers for prediction, diagnosis, and monitoring of Alzheimer's disease | ||
| 摘要 | A method for the risk detection, early diagnosis, prognosis, and monitoring of Alzheimer's disease in an individual by measuring the amount of specific biomarkers present in a bodily fluid and comparing them to a reference level of biomarkers in a sample from a healthy person, a person previously diagnosed with Alzheimer's disease, or an earlier sample from the individual of interest. | ||
| 申请公布号 | US9529002(B2) | 申请公布日期 | 2016.12.27 |
| 申请号 | US201414325073 | 申请日期 | 2014.07.07 |
| 申请人 | Rai Balwant;Kaur Jasdeep | 发明人 | Rai Balwant;Kaur Jasdeep |
| 分类号 | G01N33/53;G01N33/543;G01N33/68;G01N21/64;G01N21/93;G01N21/84;G01N21/77 | 主分类号 | G01N33/53 |
| 代理机构 | Rylander & Associates, PC | 代理人 | Rylander & Associates, PC ;Malone Janina A.;Hunt Philip R. M. |
| 主权项 | 1. A kit for determining whether a patient has Alzheimer's disease comprising a solid support on which a plurality of agents have been affixed which in combination bind to Aβ40, Aβ42, alpha amylase, and at least one or more additional biomarkers selected from the group of biomarkers consisting of IGF-I, IGF-II, IL-1 beta, TNF-alpha, wherein each agent binds to a different single biomarker. | ||
| 地址 | Haryana IN | ||